Table 3.
A. MVI | ||
---|---|---|
OR (95% CI) | p-value | |
AFP* | 5.471 (1.660-18.034) | 0.005 |
Albumin* | 0.780 (0.609-0.999) | 0.049 |
Radiologic tumor size* | 1.455 (1.133-1.869) | 0.003 |
OR hazard ratio, CI confidence interval, AFP α-fetoprotein. *per 1 standard deviation increase. | ||
B. RFS | ||
HR (95% CI) | p-value | |
Male | 1.502 (1.090-2.068) | 0.013 |
AFP* | 1.303 (1.145-1.483) | < 0.001 |
PLR* | 1.292 (1.129-1.479) | < 0.001 |
Microvascular invasion | 1.539 (1.174-2.017) | 0.002 |
Multiple nodules or satellites | 1.826 (1.357-2.458) | < 0.001 |
HR hazard ratio, CI confidence interval, AFP α-fetoprotein, PLR platelet to lymphocyte ratio. *per 1 standard deviation increase. | ||
C. OS. | ||
HR (95% CI) | p-value | |
Age* | 1.375 (1.171-1.614) | < 0.001 |
Male | 1.764 (1.241-2.508) | 0.002 |
INR* | 1.143(1.030-1.269) | 0.012 |
PLR* | 1.235 (1.057-1.444) | 0.008 |
Microvascular invasion | 1.763 (1.293-2.406) | < 0.001 |
Multiple nodules or satellites | 1.474 (1.067-2.037) | 0.019 |
Tumor size* | 1.297 (1.100-1.529) | 0.002 |
Cirrhosis | 2.458 (1.702-3.551) | < 0.001 |
Steatosis | 0.688 (0.497-0.952) | 0.024 |
HR hazard ratio, CI confidence interval, INR international normalized ratio, PLR platelet to lymphocyte ratio. *per 1 standard deviation increase. |